Yuanbao (YB) Q1 2026 earnings summary

Executive summary

• Achieved Q1 2026 revenues of RMB 1.32 billion, up 35.6% year-over-year, and net income of RMB 388 million, a 31.4% increase, with a net income margin of 29.5%.

• Maintained robust cash reserves of RMB 4.74 billion, supporting business expansion and profitability.

• Launched AI-powered insurance consultation and planning applications, enhancing user experience, product innovation, and claims service.

• Integrated innovative drug catalog and intelligent claims assistance, improving product offerings and claims processing.

• Board approved an annual cash dividend of US$1.26 per ADS and a US$15 million share repurchase program.

Financial highlights

• Insurance distribution services revenue reached RMB 411.3 million, up 27.8% year-over-year.

• System service revenues totaled RMB 904.6 million, up 39.8% year-over-year.

• Total operating expenses rose 29.1% year-over-year to RMB 878.6 million.

• Non-GAAP adjusted net income was RMB 408.8 million, up 31% year-over-year, with a margin of 31.1%.

• Cash and equivalents increased 71.4% year-over-year to RMB 4.74 billion as of March 31, 2026.

Outlook and guidance

• Focus remains on building integrated AI capabilities and deploying AI agents across the insurance process.

• Committed to enhancing user needs identification, product matching, and advisory services to upgrade operational efficiency and user experience.

• Will continue to invest in technology and AI to capture structural opportunities in the evolving insurance market.

• Commitment to long-term sustainable value creation for consumers, partners, and shareholders.